Infosys Acquires Two US Firms for $560 Million, ADRs Rise

Infosys Announces Strategic US Acquisitions

Infosys Ltd, India's second-largest IT services company, announced two strategic acquisitions in the United States after Indian market hours. The company will acquire Optimum Achieve Holdings, a healthcare consulting firm, and Stratus Global, an insurance technology specialist. The move sent Infosys's American Depositary Receipts (ADRs) higher in overnight trading on the NYSE, reflecting positive investor sentiment towards the company's growth strategy.

Deepening Healthcare and Insurance Expertise

The acquisitions are aimed at strengthening Infosys's domain capabilities in two high-growth verticals. Optimum Achieve Holdings, operating as Optimum Healthcare IT, is a digital transformation and consulting firm focused on the healthcare provider market. This acquisition is designed to enhance Infosys's presence in the provider segment by adding new clients, technology capabilities, and deep domain expertise. Infosys stated that Optimum's clients will gain access to its broader offerings, including the Infosys Topaz AI and Cobalt cloud platforms.

Simultaneously, Infosys will acquire Stratus Global, a prominent partner of Guidewire Software, which provides transformation solutions to property and casualty (P&C) insurers. By integrating Stratus's specialized consulting expertise with its own global reach and AI capabilities, Infosys aims to better support insurers with core system modernization, cloud adoption, and data-driven transformation projects. This move also expands Infosys's footprint with new insurance customers globally.

Financial Details of the Transactions

Infosys will pay up to $165 million for Optimum Achieve Holdings. This amount includes upfront payments and potential earnouts, but excludes management incentives and retention bonuses. For Stratus Global, the total consideration is $15 million, structured similarly with upfront and earnout components. Both transactions are subject to standard closing conditions and are expected to be completed in the first quarter of fiscal year 2027.

Immediate Market Reaction

The announcement was met with a positive response from the market. Infosys's ADRs, which trade on the NYSE, rose 0.69% to settle at $13.17 apiece following the news. The stock continued to edge higher in after-hours trading, indicating investor approval of the strategic deployment of capital to accelerate growth in key verticals.

Context of Strong Recent Performance

These acquisitions come on the back of a strong performance by Infosys in recent quarters. The company's Q3 FY26 results had previously boosted investor confidence, leading to a nearly 10% surge in its ADRs in January. During that quarter, Infosys reported robust deal wins totaling $1.8 billion, a significant increase from $1.1 billion in the previous quarter, partly driven by a large contract with the UK's National Health Service (NHS).

More importantly, the company raised its full-year revenue growth guidance for FY26 to a range of 3% to 3.5% in constant currency terms, up from the earlier 2% to 3%. This upward revision signaled an improving demand environment and management's confidence in future growth, setting a positive backdrop for these strategic investments.

Analyst Outlook and Industry Trends

Analysts have maintained a broadly positive outlook on Infosys, citing its strong deal pipeline and improving demand visibility. Brokerages like HSBC, Jefferies, and Nuvama had reiterated 'Buy' ratings following the Q3 results. The consensus view is that Infosys is well-positioned to capture enterprise demand for AI and cloud solutions. These acquisitions align directly with that strategy, using targeted buyouts to gain specialized skills and market access rather than relying solely on organic growth.

The move also reflects a broader industry trend where large IT service providers are acquiring niche firms to fill capability gaps and accelerate their expansion into high-margin digital transformation services. By purchasing established players in the healthcare and P&C insurance sectors, Infosys can immediately offer more comprehensive solutions to its clients.

Conclusion

Infosys's acquisition of Optimum Healthcare IT and Stratus Global for a combined $160 million marks a significant step in its strategy to deepen industry-specific expertise. The move leverages the company's strong financial position to accelerate growth in the lucrative US healthcare and insurance markets. With the deals expected to close in early FY27, the focus will now shift to the successful integration of these firms to realize the anticipated synergies and enhance value for clients and shareholders.